BCRX
BioCryst Pharmaceuticals Inc
8.60$
-2.4%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +20.0% | -16.7% | +0.0% | +33.8% | +56.8% | +18.8% | -11.7% | -11.9% | -10.8% | -5.0% | +66.8% | +18.7% | -0.8% | +40.6% | -60.9% | -29.1% | -51.6% | -41.8% | +1.7% | +168.3% | +45.8% | +9.4% | -6.0% | +3.3% | +3.9% | +84.9% | +15.2% | -24.7% | +11.5% | |
| – | – | – | – | – | +17.9% | -2.5% | -0.4% | +328.2% | -94.8% | +12,550.7% | +70.5% | +3.0% | -99.9% | +14.1% | -24.3% | -12.7% | +4.8% | +133.0% | -4.6% | -12.6% | +48.7% | -25.6% | +88.6% | -16.5% | +134.1% | +29.0% | +24.4% | +17.6% | +30.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -44.0% | -119.8% | – | +111.0% | -25.1% | +76.5% | -23.0% | +72.8% | -14.6% | +114.0% | +329.8% | – | – | – | |
| – | -266.7% | – | – | – | +184.5% | -224.1% | – | +418.6% | +16.8% | +1,320.2% | -112.4% | – | – | – | – | -129.3% | – | -65.7% | +1,357.1% | -139.7% | – | -137.8% | – | – | -69.8% | -825.6% | – | – | – | |
| – | +266.7% | -63.6% | +150.0% | +172.3% | -4.4% | -84.3% | -87.3% | +430.6% | +80.2% | +208.6% | +217,783.5% | -100.0% | -50.2% | -46.2% | -83.1% | +105.5% | -73.5% | +253.3% | +4,732.1% | +3.0% | -93.8% | +11.6% | -6.3% | +49.9% | +364.0% | -43.4% | +60.5% | -48.2% | +119.6% | |
| – | – | -43.1% | -922.4% | – | +1,292.6% | -45.0% | -24.9% | -133.7% | +305.9% | +8.5% | +20.4% | – | -213.2% | – | +5,019.7% | +119.9% | -113.9% | +1,053.2% | -55.0% | – | -384.4% | – | +1,534.5% | -108.8% | – | -911.4% | +2.5% | – | -126.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | -96.8% | +1,117.3% | – | +34.5% | +346.0% | -95.1% | -94.2% | +42,670.0% | -58.5% | +41.5% | +38.8% | -40.5% | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +0.0% | -1.4% | -99.5% | +5,086.9% | +207.8% | +246.3% | +335.7% | -75.1% | -20.1% | -102.9% | +17,622.4% | |
| – | -99.4% | +3,350.0% | +610.1% | -96.9% | -87.9% | -34.1% | +634.2% | +2,286.5% | +156.9% | -94.6% | +2,154.8% | -99.0% | +7,084.7% | -98.3% | +2,760.0% | -28.6% | +78.5% | +269.7% | -95.1% | +325.3% | +482.3% | -53.9% | +58.5% | +205.5% | +18.8% | -75.5% | -63.1% | -117.7% | +5,670.6% | |
| – | – | +8,400.0% | -143.5% | – | – | -148.4% | – | – | +4,042.7% | -221.8% | – | -133.0% | – | -246.4% | – | +57.6% | -93.9% | +12,125.6% | -176.8% | – | – | -189.8% | – | +81.4% | +47.1% | -186.3% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | -100.7% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.